A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Insulin With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-254)

NCT01590797 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

467

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Sitagliptin
DRUG: Placebo
BIOLOGICAL: Insulin
DRUG: Metformin

Sponsor

Merck Sharp & Dohme LLC